Skip to content

In the BioHarmony Drug Report Database

Hydrochlorothiazide

Esidrix, Hydrodiuril, Microzide, Oretic, Rasilez (hydrochlorothiazide) is a small molecule pharmaceutical. Hydrochlorothiazide was first approved as Esidrix on 1982-01-01. It is used to treat edema, heart failure, hypertension, and nephrotic syndrome in the USA. It has been approved in Europe to treat hypertension. The pharmaceutical is active against solute carrier family 12 member 3. In addition, it is known to target glutamate receptor 2.
Trade Name Rasilez HCT
Common Name Hydrochlorothiazide
Indication edema, heart failure, hypertension, nephrotic syndrome
Drug Class Diuretics (thiazide derivatives)
Hydrochlorothiazide
Get full access now